Dynamic Risk Assessment Urged for Steatotic Liver Disease

Steatotic liver disease (SLD) encompasses overlapping phenotypes influenced by alcohol use and metabolic risks. Experts recommend dynamic assessment of these factors to improve risk stratification and care, as static thresholds may misclassify patients. Management should involve coordinated care across specialties, and future trials should include patients with concurrent alcohol use.